Skip to main content
. 2021 May 8;87(11):4439–4449. doi: 10.1111/bcp.14872

FIGURE 1.

FIGURE 1

Study design of part A (four‐treatment open label sequential design) and B (five‐treatment randomized, placebo and positive comparator‐controlled crossover design) and the number of subjects that started and completed the treatment